Figure 2From: Voluntary acceptance and consumption of two oral ciclosporin formulations in dogs: two randomised, controlled studies Product consumption in study 1. This chart presents the level of consumption for the tested products. * Statistical difference between the products (p < 0.05). Total consumption was significantly higher for Cyclavance® than Atopica® (p < 0.001).Back to article page